“Renowned infection researcher recommends broad vaccination campaign against RS virus”

2023-05-07 01:06:00

Berlin – In the fight against the RS virus, the renowned infection researcher Beate Kampmann advises a broad vaccination campaign as soon as a vaccine against the virus is approved in Germany. “It makes sense to vaccinate small children, risk groups and older people against RSV, because this is where the more serious complications occur,” said the director of the Institute for International Health at the Berlin Charité to the newspapers of the Funke media group (Sunday editions).

A vaccine against the respiratory syncytial virus (RSV) was approved for the first time in the United States at the end of last week. Kampmann also expressed his confidence that there would soon be an RSV vaccine that pregnant women could be vaccinated with in order to offer newborns protection: “I myself have been involved in studies that deal with this, especially protection for infants by vaccinating the mothers during pregnancy.” The vaccine with this indication is currently being advised by the regulatory authorities. “We expect a decision in the fall,” said Kampmann.

She is an expert in pediatric infectiology and international child health. The respiratory syncytial virus affects the respiratory tract and is mainly transmitted via droplet or smear infection.

Free Report: Fallen Big Techs – Here now up to 200% are waving!

Market Expert Is Convinced These Big Tech Stocks Have Fallen Too Far and Are Coming Back!

Click here